Conditionally Active Biological Proteins
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/US2016/019242, filed Feb 24, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,254,932 | Conditionally Active Biological Proteins In force · High confidence | BioAtla, Inc. | In force | High confidence | ||
| US 12,110,611 | Conditionally Active Biological Proteins In force · Low confidence | BioAtla, Inc. | In force | Low confidence | ||
| US 10,563,194 | Conditionally Active Biological Proteins In force · High confidence | BioAtla, Inc. | In force | High confidence | ||
| US 11,472,876 | Conditionally Active Polypeptides In force · Medium confidence | BioAtla, Inc. | In force | Medium confidence | ||
| Application 17/820,913 | Conditionally Active Polypeptides Pending Not granted | BioAtla, Inc. | Pending | Not granted | ||
| Application 18/820,633 | Conditionally Active Biological Proteins Pending Not granted | BioAtla Inc. | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by BioAtla Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.